LENZ
NASDAQ · Pharmaceuticals
Lenz Therapeutics Inc
$5.36
+0.14 (+2.68%)
Open$5.29
Previous Close$5.22
Day High$5.42
Day Low$5.21
52W High$50.40
52W Low$4.68
Volume—
Avg Volume870.2K
Market Cap168.06M
P/E Ratio—
EPS$-3.59
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+160.8% upside
Current
$5.36
$5.36
Target
$13.98
$13.98
$9.74
$13.98 avg
$16.17
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 21.01M | 61.59M | 55.54M |
| Net Income | -90,381,162 | 19.38M | 14.59M |
| Profit Margin | -430.3% | 31.5% | 26.3% |
| EBITDA | -99,982,754 | 32.48M | 26.94M |
| Free Cash Flow | — | 24.80M | 19.95M |
| Rev Growth | — | +17.7% | +18.8% |
| Debt/Equity | — | 0.99 | 1.18 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |